Europe UK (Commonwealth Union) – Genomic sequencing has become a key focus in recent years particularly with recent technology for providing enhanced analytical models to better understand genetic diseases and conditions that may arise. Much of the new technology have provided better analysis models of patterns and behavior.
A new study has found that detection and management in routine care of inherited rare and serious conditions could be enhanced with the aid of genome sequencing,
Since recent years standard genetic testing focused on lower proportions of genes but with 1000s more linked to diseases a new approach was explored.
The Scottish Genomes Partnership (SGP) was the name given to describe the project which will be made available for the healthcare policy and funding decisions, as described by experts.
The sequencing of entire genomes incorporates reading the whole sequence of an individual’s genes with the marking of variants that differ from usual patterns.
Researchers are able to contrast these against genes known to bring about disease and then take a closer look at this shortlist of variants to mark the one that might be a significant factor to an individual’s condition.
Rare conditions impact roughly 8% of the population of Scotland with approximately 80% of these conditions linked to a genetic factor.
There are over 150,000 gene abnormalities known to lead to developmental and learning difficulties and a host of conditions effecting long-term health, however many were undiagnosed.
As members of the SGP, the University of Edinburgh researchers sequenced 1,000 genomes from persons in Scotland with rare conditions and their families, where prior genetic testing had not identified a genetic factor.
Professor Zosia Miedzybrodzka, of the University of Aberdeen says “Having an undiagnosed genetic condition brings a huge amount of worry for those affected but it is our hope that diagnosis through genome sequencing can bring answers and improve the lives of patients and their families.”
